Whilst a number of neuroendocrine afferent signals are implicated in body-w
eight homeostasis, the major efferent pathway is the sympathetic nervous sy
stem (SNS), which affects both energy expenditure and substrate utilization
. Thyroid hormones and their interactions with the SNS may also have a role
to play. Some of the variability in resting energy expenditure can be expl
ained by differences in SNS activity, and beta-blockade can reduce energy e
xpenditure and diet-induced thermogenesis in Caucasians. Excess energy inta
ke leads to SNS activation and increased diet-induced thermogenesis. A rela
tionship has also been demonstrated between spontaneous physical activity a
nd SNS activity. In many animal models the SNS activates brown adipose tiss
ue thermogenesis, hence increasing diet-induced thermogenesis and dissipati
ng excess energy as heat. This effect is mediated via beta(3)-adrenoceptors
and activation of an uncoupling protein unique to brown adipose tissue. Ho
mologous proteins have been identified in human tissues and may play a role
in human energy expenditure. How the SNS is implicated in this process is
unclear at present. beta(3)-Adrenoceptor polymorphism has been associated b
oth with lower resting energy expenditure in some populations and with redu
ced autonomic nervous system activity. SNS effects on substrate cycling may
also play a role. In the development of obesity the effects of the SNS in
promoting lipolysis and fat oxidation are likely to be at least as importan
t as its effects on thermogenesis. beta-Blockade has relatively small effec
ts on energy expenditure, but more pronounced effects on reducing Lipid oxi
dation, so tending to favour fat storage and weight gain. Low lipid oxidati
on is a risk factor for weight gain, and there is some evidence that low ba
sal sympathetic nerve activity in muscle is associated with this process. O
verall, the relationship between SNS activity and obesity is complex, with
evidence of low SNS activity occurring in some, but not all, studies.